Resources from the same session
661MO - Evaluation of the DNA damage response (DDR) network as predictor of nivolumab efficacy in head and neck squamous cell carcinoma (HNSCC)
Presenter: Panagiota Economopoulou
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast